Creatd Invited To Join Exclusive Shopify Investor Partner Program

Creatd, Inc. (Nasdaq CM: CRTD) ("Creatd" or the "Company"), the parent company of Creatd Ventures, today provided an update on its ongoing efforts to strengthen the technology supporting Creatd

Creatd, Inc. (Nasdaq CM: CRTD) (“Creatd” or the “Company”), the parent company of Creatd Ventures, today provided an update on its ongoing efforts to strengthen the technology supporting Creatd Ventures by joining the Shopify Investor Partner Program. This invite-only elite program gives Creatd’s CPG brands access to exclusive Shopify resources, including first-in-line access to Shopify’s data and any new roll-outs on the platform, as well as premier offers from Shopify. Shopify, Inc. is publicly traded on the New York Stock Exchange.

Commented Creatd Ventures’ CEO Thomas Punch, “We are honored to be invited to join the Shopify Investor Partner Program. We are both aligned in giving creators the opportunity to become entrepreneurs. Additionally, this partnership opens up new possibilities for us to invest and expand in our e-commerce technology stack and continue scaling Creatd’s fastest-growing revenue stream, our Ventures pillar.”

Total
0
Shares
Related Posts
Read More

Alterity Therapeutics Announced Monday, Granting of New Composition of Matter Patent and Exclusive License Agreement for Assets in Alzheimer’s Disease

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) announced that the composition of matter patent previously allowed by the United States Patent and Trademark Office (USPTO) has now been granted. The patent, entitled "Compounds for and methods of treating diseases" (No. 11,603,364), covers more than 100 novel compounds with an acyl hydrazone (AH) structure and provides 20 years of exclusivity.

ATHE